NCT02824341

Brief Summary

Up to 60% of Parkinson's Disease (PD) patients suffer from REM sleep behavior disorder (RBD), a parasomnia. This disorder is thought to be related to a dysfunction of limbic system and brainstem. Impulse control disorders (ICD) are found in about 14% of PD patients taking dopaminergic drugs. These disorders are thought to be related to a dysfunction of meso-cortico-limbic pathways which belong to the so-called "reward system". A strong link was found between these two disorders and therefore the investigators believe that RBD is associated with impaired reward system. The main objective of this study is to evaluate differences in brain activation between PD patients with and without RBD. The investigators hypothesize that PD patients with RBD have a more severe dysfunction of the reward system (hypoactivation of the meso-cortico-limbic pathway) than patients without RBD, explaining their susceptibility to ICD when exposed to high doses of dopaminergic treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 24, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 6, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
Last Updated

March 16, 2018

Status Verified

March 1, 2018

Enrollment Period

1.7 years

First QC Date

June 24, 2016

Last Update Submit

March 14, 2018

Conditions

Keywords

Parkinson 's diseaseREM sleep behavior disorderReward systemFunctional MRI

Outcome Measures

Primary Outcomes (1)

  • BOLD signal variation in each region of interest

    BOLD signal variation in each region of interest (ventral tegmental area, accumbens nucleus, limbic cortex, prefrontal cortex) at the time of realisation of fMRI.

    at week 1

Secondary Outcomes (7)

  • Reaction time to the task

    at week 1

  • Performance score to the task

    at week 1

  • Hoehn et Yahr score

    at week 1

  • The Unified Parkinson Disease Rating scale (MDS-UPDRS) score

    at week 1

  • The Beck Depression Inventory score

    at week 1

  • +2 more secondary outcomes

Study Arms (3)

Parkinson's disease patients with RBD

OTHER

The investigators hypothesize that PD patients with RBD have a more severe dysfunction of the reward system (hypoactivation of the meso-cortico-limbic pathway) than patients without RBD, explaining their susceptibility to ICD when exposed to high doses of dopaminergic treatment.

Device: fMRI

Parkinson's disease without RBD

OTHER

The investigators hypothesize that PD patients with RBD have a more severe dysfunction of the reward system (hypoactivation of the meso-cortico-limbic pathway) than patients without RBD, explaining their susceptibility to ICD when exposed to high doses of dopaminergic treatment.

Device: fMRI

Healthy volunteers

OTHER

The investigators hypothesize that PD patients with RBD have a more severe dysfunction of the reward system (hypoactivation of the meso-cortico-limbic pathway) than patients without RBD, explaining their susceptibility to ICD when exposed to high doses of dopaminergic treatment.

Device: fMRI

Interventions

fMRIDEVICE
Healthy volunteersParkinson's disease patients with RBDParkinson's disease without RBD

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Parkinson's disease (UK Parkinson's Disease Society Brain Bank Criteria)
  • men or women 45 to 80 years old
  • diagnosis of RBD made with polysomnographic recording

You may not qualify if:

  • Previous history of psychosis or psychiatric disease
  • History of stroke or vascular lesion on MRI.
  • pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Clermont-Ferrand

Clermont-Ferrand, 63003, France

Location

MeSH Terms

Conditions

Parkinson DiseaseREM Sleep Behavior Disorder

Interventions

Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesREM Sleep ParasomniasParasomniasSleep Wake DisordersMental Disorders

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Franck DURIF

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2016

First Posted

July 6, 2016

Study Start

October 1, 2015

Primary Completion

June 1, 2017

Study Completion

October 1, 2017

Last Updated

March 16, 2018

Record last verified: 2018-03

Locations